Correction to: Nature Communications 10.1038/s41467-023-37397-w, published online 20 April 2023
In this article the author name Jiankang Fang was incorrectly written as Jiangkang Fang. The original article has been corrected.
. 2023 Sep 27;14:6018. doi: 10.1038/s41467-023-41842-1
Author Correction: Sema3C signaling is an alternative activator of the canonical WNT pathway in glioblastoma
Jing Hao
1, Xiangzi Han
1, Haidong Huang
1, Xingjiang Yu
1, Jiankang Fang
1, Jianjun Zhao
1, Richard A Prayson
2,3, Shideng Bao
1, Jennifer S Yu
1,3,4,✉
Jing Hao
1Center for Cancer Stem Cell Biology, Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195 USA
Find articles by Jing Hao
Xiangzi Han
1Center for Cancer Stem Cell Biology, Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195 USA
Find articles by Xiangzi Han
Haidong Huang
1Center for Cancer Stem Cell Biology, Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195 USA
Find articles by Haidong Huang
Xingjiang Yu
1Center for Cancer Stem Cell Biology, Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195 USA
Find articles by Xingjiang Yu
Jiankang Fang
1Center for Cancer Stem Cell Biology, Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195 USA
Find articles by Jiankang Fang
Jianjun Zhao
1Center for Cancer Stem Cell Biology, Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195 USA
Find articles by Jianjun Zhao
Richard A Prayson
2Department of Anatomic Pathology, Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195 USA
3Burkhardt Brain Tumor and Neuro-Oncology Center, Neurological Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195 USA
Find articles by Richard A Prayson
Shideng Bao
1Center for Cancer Stem Cell Biology, Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195 USA
Find articles by Shideng Bao
Jennifer S Yu
1Center for Cancer Stem Cell Biology, Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195 USA
3Burkhardt Brain Tumor and Neuro-Oncology Center, Neurological Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195 USA
4Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195 USA
Find articles by Jennifer S Yu
1Center for Cancer Stem Cell Biology, Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195 USA
2Department of Anatomic Pathology, Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195 USA
3Burkhardt Brain Tumor and Neuro-Oncology Center, Neurological Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195 USA
4Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195 USA
✉
Corresponding author.
Collection date 2023.
Subject terms: Cancer stem cells, CNS cancer
© The Author(s) 2023
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
PMCID: PMC10533545 PMID: 37758699
This corrects the article "Sema3C signaling is an alternative activator of the canonical WNT pathway in glioblastoma", 2262.